| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Skye Bioscience, Inc. (SKYE) have been net sellers, shedding 1,115,622 shares worth roughly $889K on balance. In the past 30 days, 0 insiders bought and 2 sold. Sales set the recent tone.
On the other side, 2 insiders reduced their position over the period. SKYE sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.42M | - | - | |
| Other | 150.0K | - | - | |
| Other | 125.0K | - | - | |
| Other | 125.0K | - | - | |
| CFO | 125.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Schwab Andrew J.53 | Director, 10% Owner | Sell | 148,079 | $1.62 | $239,555.19 | -100% | - | - | |
| Sep 23, 2026 | 5am Partners Vii, LLC74 | 10% Owner | Sell | 148,079 | $1.62 | $239,555.19 | -100% | - | - | |
| Sep 16, 2026 | 5am Partners Vii, LLC74 | 10% Owner | Sell | 33,892 | $1.91 | $64,733.72 | -85.8% | - | - | |
| Sep 16, 2026 | Schwab Andrew J.53 | Director, 10% Owner | Sell | 33,892 | $1.91 | $64,733.72 | -85.8% | - | - | |
| Aug 20, 2026 | Schwab Andrew J.53 | Director, 10% Owner | Sell | 375,840 | $0.37 | $140,313.00 | -3.9% | - | - | |
| Aug 20, 2026 | 5am Partners Vii, LLC74 | 10% Owner | Sell | 375,840 | $0.37 | $140,313.00 | -3.9% | - | - | |
| Aug 22, 2025 | Schwab Andrew J.53 | Director, 10% Owner | Sell | 231,405 | $3.46 | $800,548.50 | -80.1% | -62.0% | - | |
| Aug 22, 2025 | 5am Partners Vii, LLC74 | 10% Owner | Sell | 231,405 | $3.46 | $800,548.50 | -80.1% | -62.0% | - | |
| Nov 18, 2024 | Diep Tuan Tu | Chief Development Officer | Sell | 19,574 | $4.99 | $97,721.86 | -19.2% | -31.8% | -70.8% | |
| Nov 18, 2024 | Arsenault Kaitlyn | Chief Financial Officer | Sell | 43,396 | $4.99 | $216,652.44 | -20.7% | -31.8% | -70.8% |